Iron-ascorbate-mediated lipid peroxidation causes epigenetic changes in the antioxidant defense in intestinal epithelial cells: impact on inflammation

PLoS One. 2013 May 22;8(5):e63456. doi: 10.1371/journal.pone.0063456. Print 2013.

Abstract

Introduction: The gastrointestinal tract is frequently exposed to noxious stimuli that may cause oxidative stress, inflammation and injury. Intraluminal pro-oxidants from ingested nutrients especially iron salts and ascorbic acid frequently consumed together, can lead to catalytic formation of oxygen-derived free radicals that ultimately overwhelm the cellular antioxidant defense and lead to cell damage.

Hypothesis: Since the mechanisms remain sketchy, efforts have been exerted to evaluate the role of epigenetics in modulating components of endogenous enzymatic antioxidants in the intestine. To this end, Caco-2/15 cells were exposed to the iron-ascorbate oxygen radical-generating system.

Results: Fe/Asc induced a significant increase in lipid peroxidation as reflected by the elevated formation of malondialdehyde along with the alteration of antioxidant defense as evidenced by raised superoxide dismutase 2 (SOD2) and diminished glutathione peroxidase (GPx) activities and genes. Consequently, there was an up-regulation of inflammatory processes illustrated by the activation of NF-κB transcription factor, the higher production of interleukin-6 and cycloxygenase-2 as well as the decrease of IκB. Assessment of promoter's methylation revealed decreased levels for SOD2 and increased degree for GPx2. On the other hand, pre-incubation of Caco-2/15 cells with 5-Aza-2'-deoxycytidine, a demethylating agent, or Trolox antioxidant normalized the activities of SOD2 and GPx, reduced lipid peroxidation and prevented inflammation.

Conclusion: Redox and inflammatory modifications in response to Fe/Asc -mediated lipid peroxidation may implicate epigenetic methylation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antioxidants / metabolism
  • Ascorbic Acid / adverse effects*
  • Caco-2 Cells
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Cell Survival / genetics
  • Cyclooxygenase 2 / genetics
  • Cyclooxygenase 2 / metabolism
  • DNA Methylation / drug effects
  • DNA Methylation / genetics
  • Epigenesis, Genetic / drug effects*
  • Epigenesis, Genetic / genetics
  • Epithelial Cells / drug effects*
  • Epithelial Cells / metabolism
  • Free Radicals / adverse effects
  • Free Radicals / metabolism
  • Gene Expression / drug effects
  • Gene Expression / genetics
  • Glutathione Peroxidase / genetics
  • Glutathione Peroxidase / metabolism
  • Humans
  • I-kappa B Kinase / genetics
  • I-kappa B Kinase / metabolism
  • Inflammation / chemically induced*
  • Inflammation / genetics
  • Inflammation / metabolism
  • Interleukin-6 / metabolism
  • Intestines / drug effects*
  • Intestines / embryology
  • Iron / adverse effects*
  • Lipid Peroxidation / drug effects*
  • Lipid Peroxidation / genetics
  • Malondialdehyde / metabolism
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Promoter Regions, Genetic / drug effects
  • Promoter Regions, Genetic / genetics
  • Superoxide Dismutase / genetics
  • Superoxide Dismutase / metabolism
  • Up-Regulation / drug effects
  • Up-Regulation / genetics

Substances

  • Antioxidants
  • Free Radicals
  • Interleukin-6
  • NF-kappa B
  • Malondialdehyde
  • Iron
  • Glutathione Peroxidase
  • Cyclooxygenase 2
  • Superoxide Dismutase
  • superoxide dismutase 2
  • I-kappa B Kinase
  • Ascorbic Acid

Grants and funding

This study was supported by the J. A. DeSève Research Chair in Nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.